Astria Therapeutics Inc.

NASDAQ: ATXS · Real-Time Price · USD
6.85
0.09 (1.33%)
At close: Aug 15, 2025, 3:59 PM
6.85
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

Astria Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-111.56M -83.03M -53.5M -194.98M
Interest Income
17.36M 10.2M 1.72M 122K
Pretax Income
-94.26M -72.89M -51.83M -194.91M
Net Income
-94.26M -72.89M -51.83M -194.91M
Selling & General & Admin
34.45M 25.7M 19.24M 14.81M
Research & Development
77.11M 57.33M 34.26M 15.55M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
111.56M 83.03M 53.5M 30.36M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-111.56M 83.03M 53.5M 30.36M
Income Tax Expense
n/a n/a n/a -164.74M
Shares Outstanding (Basic)
56.16M 30.12M 14.62M 8.93M
Shares Outstanding (Diluted)
56.16M 30.12M 14.62M 8.93M
EPS (Basic)
-1.68 -2.42 -3.55 -24.58
EPS (Diluted)
-1.68 -2.42 -3.55 -24.58
EBITDA
-94.26M -83.03M -53.5M -194.98M
EBIT
-94.26M -67.83M -51.83M -30.36M
Depreciation & Amortization
n/a -15.2M 228.49K -164.62M